Preoperative Window of Opportunity Study With Giredestrant (GDC-9545) or Tamoxifen in Premenopausal Women With ER[+]/HER2[-] & Ki67 ≥10% Early Breast Cancer
Conditions: Breast Cancer; Breast Cancer, Early-Onset Interventions: Drug: Giredestrant; Drug: Tamoxifen Sponsor: MedSIR Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials